Advertisement
Screener

SANUWAVE Health, Inc. (SNWV) Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Options Forfeited, Weighted Average Grant Date Fair Value

2.8 / 5 stars · 36/65 Roast Me

SANUWAVE Health, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Options Forfeited, Weighted Average Grant Date Fair Value

SANUWAVE Health, Inc. (SNWV) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Options Forfeited, Weighted Average Grant Date Fair Value of $0.00 per share for the 12-month period ending 2019-12-31, per its 10-K filed 2020-03-30.

Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value

us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue · last filed 2020-03-30

  • SANUWAVE Health, Inc. share-based compensation arrangement by share-based payment award, options, nonvested options forfeited, weighted average grant date fair value for the quarter ending 2018-06-30 was $0.00.
  • SANUWAVE Health, Inc. share-based compensation arrangement by share-based payment award, options, nonvested options forfeited, weighted average grant date fair value for the quarter ending 2018-03-31 was $0.00.
  • SANUWAVE Health, Inc. share-based compensation arrangement by share-based payment award, options, nonvested options forfeited, weighted average grant date fair value for the quarter ending 2015-09-30 was $0.55, a 0.00% change year-over-year.
  • SANUWAVE Health, Inc. share-based compensation arrangement by share-based payment award, options, nonvested options forfeited, weighted average grant date fair value for the quarter ending 2014-09-30 was $0.55.
  • SANUWAVE Health, Inc. share-based compensation arrangement by share-based payment award, options, nonvested options forfeited, weighted average grant date fair value for fiscal 2019 was $0.00.
  • SANUWAVE Health, Inc. share-based compensation arrangement by share-based payment award, options, nonvested options forfeited, weighted average grant date fair value for fiscal 2018 was $0.00.
  • SANUWAVE Health, Inc. share-based compensation arrangement by share-based payment award, options, nonvested options forfeited, weighted average grant date fair value for fiscal 2017 was $0.00.
  • SANUWAVE Health, Inc. share-based compensation arrangement by share-based payment award, options, nonvested options forfeited, weighted average grant date fair value for fiscal 2016 was $0.00, a 100.00% decline from fiscal 2015.
Period endShare-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Options Forfeited, Weighted Average Grant Date Fair Value 3 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Options Forfeited, Weighted Average Grant Date Fair Value 12 month
2019-12-31$0.00
10-K · filed 2020-03-30
2018-12-31$0.00
10-K · filed 2020-03-30
2018-06-30$0.00
10-Q · filed 2018-08-14
2018-03-31$0.00
10-Q · filed 2018-08-14
2017-12-31$0.00
10-K · filed 2019-04-01
2016-12-31$0.00
10-K · filed 2018-03-29
2015-12-31$0.55
10-K · filed 2017-03-31
2015-09-30$0.55
10-Q · filed 2015-11-12
2014-12-31$0.39
10-K · filed 2015-03-03
2014-09-30$0.55
10-Q · filed 2014-11-12
2014-06-30$0.35
10-Q · filed 2014-11-12
2013-12-31$0.50
10-K · filed 2015-03-03
2012-12-31$3.41
10-K · filed 2014-03-31

Similar stocks

Stock NameCountryMarket CapPE Ratio
NEPHROS INC (NEPH)United States$0.046B23.02
Sensus Healthcare, Inc. (SRTS)United States$0.048B-3.24
InspireMD, Inc. (NSPR)$0.033B
PAVmed Inc. (PAVM)United States$0.031B-3.00
Spectral AI, Inc. (MDAI)United States$0.052B
Xtant Medical Holdings, Inc. (XTNT)United States$0.053B
Glucotrack, Inc. (GCTK)United States$0.027B
ACCURAY INC (ARAY)United States$0.027B-0.63
TELA Bio, Inc. (TELA)United States$0.057B-0.82
HeartBeam, Inc. (BEAT)United States$0.022B-2.08